Atlas Trials

Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk

Clinical trial NCT07347977 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07347977
Sponsor
First Affiliated Hospital of Ningbo University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small Cell Lung CancerRecurrenceSurvival Analysis
Start date
2026-01-01
Primary completion
2029-09-30
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.